Does metoclopramide supplement postoperative analgesia using patient- controlled analgesia with morphine in patients undergoing elective cesarean delivery?

B. I. Danzer, David Birnbach, D. J. Stein, M. M. Kuroda, D. M. Thys

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background and Objectives. Recent studies have shown that metoclopramide may decrease postoperative narcotic requirements in patients undergoing second-trimester induced abortions or prosthetic hip surgery. It is often used to decrease the incidence of nausea and vomiting in the patient undergoing cesarean delivery under regional anesthesia. If metoclopramide were found to be an analgesic adjunct in these patients, it would offer an additional impetus for its routine use. Methods. After elective cesarean delivery under spinal anesthesia, 32 patients were monitored for initial and 24-hour postoperative morphine requirements via intravenous patient- controlled analgesia. These patients were divided into two groups. Prior to spinal block, group 1 (n = 17) received 10 mg intravenous metoclopramide, and group 2 (n = 15) received an intravenous saline placebo. Results. No differences were found between groups in the time from spinal placement to the time of pain onset, the amount of morphine necessary to initially achieve comfort, or 24-hour postoperative morphine requirements. (P > .05). Conclusions. This study demonstrates that metoclopramide decreases intraoperative nausea but does not supplement analgesia in patients undergoing elective cesarean delivery.

Original languageEnglish
Pages (from-to)424-427
Number of pages4
JournalRegional Anesthesia
Volume22
Issue number5
StatePublished - Oct 14 1997
Externally publishedYes

Fingerprint

Patient-Controlled Analgesia
Metoclopramide
Analgesia
Morphine
Nausea
Conduction Anesthesia
Induced Abortion
Spinal Anesthesia
Narcotics
Second Pregnancy Trimester
Vomiting
Analgesics
Hip
Placebos
Pain
Incidence

Keywords

  • Cesarean delivery
  • Metoclopramide
  • Morphine
  • Patient-controlled analgesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Does metoclopramide supplement postoperative analgesia using patient- controlled analgesia with morphine in patients undergoing elective cesarean delivery? / Danzer, B. I.; Birnbach, David; Stein, D. J.; Kuroda, M. M.; Thys, D. M.

In: Regional Anesthesia, Vol. 22, No. 5, 14.10.1997, p. 424-427.

Research output: Contribution to journalArticle

@article{cc1789b4da6f4e35b128bd26ff58b677,
title = "Does metoclopramide supplement postoperative analgesia using patient- controlled analgesia with morphine in patients undergoing elective cesarean delivery?",
abstract = "Background and Objectives. Recent studies have shown that metoclopramide may decrease postoperative narcotic requirements in patients undergoing second-trimester induced abortions or prosthetic hip surgery. It is often used to decrease the incidence of nausea and vomiting in the patient undergoing cesarean delivery under regional anesthesia. If metoclopramide were found to be an analgesic adjunct in these patients, it would offer an additional impetus for its routine use. Methods. After elective cesarean delivery under spinal anesthesia, 32 patients were monitored for initial and 24-hour postoperative morphine requirements via intravenous patient- controlled analgesia. These patients were divided into two groups. Prior to spinal block, group 1 (n = 17) received 10 mg intravenous metoclopramide, and group 2 (n = 15) received an intravenous saline placebo. Results. No differences were found between groups in the time from spinal placement to the time of pain onset, the amount of morphine necessary to initially achieve comfort, or 24-hour postoperative morphine requirements. (P > .05). Conclusions. This study demonstrates that metoclopramide decreases intraoperative nausea but does not supplement analgesia in patients undergoing elective cesarean delivery.",
keywords = "Cesarean delivery, Metoclopramide, Morphine, Patient-controlled analgesia",
author = "Danzer, {B. I.} and David Birnbach and Stein, {D. J.} and Kuroda, {M. M.} and Thys, {D. M.}",
year = "1997",
month = "10",
day = "14",
language = "English",
volume = "22",
pages = "424--427",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Does metoclopramide supplement postoperative analgesia using patient- controlled analgesia with morphine in patients undergoing elective cesarean delivery?

AU - Danzer, B. I.

AU - Birnbach, David

AU - Stein, D. J.

AU - Kuroda, M. M.

AU - Thys, D. M.

PY - 1997/10/14

Y1 - 1997/10/14

N2 - Background and Objectives. Recent studies have shown that metoclopramide may decrease postoperative narcotic requirements in patients undergoing second-trimester induced abortions or prosthetic hip surgery. It is often used to decrease the incidence of nausea and vomiting in the patient undergoing cesarean delivery under regional anesthesia. If metoclopramide were found to be an analgesic adjunct in these patients, it would offer an additional impetus for its routine use. Methods. After elective cesarean delivery under spinal anesthesia, 32 patients were monitored for initial and 24-hour postoperative morphine requirements via intravenous patient- controlled analgesia. These patients were divided into two groups. Prior to spinal block, group 1 (n = 17) received 10 mg intravenous metoclopramide, and group 2 (n = 15) received an intravenous saline placebo. Results. No differences were found between groups in the time from spinal placement to the time of pain onset, the amount of morphine necessary to initially achieve comfort, or 24-hour postoperative morphine requirements. (P > .05). Conclusions. This study demonstrates that metoclopramide decreases intraoperative nausea but does not supplement analgesia in patients undergoing elective cesarean delivery.

AB - Background and Objectives. Recent studies have shown that metoclopramide may decrease postoperative narcotic requirements in patients undergoing second-trimester induced abortions or prosthetic hip surgery. It is often used to decrease the incidence of nausea and vomiting in the patient undergoing cesarean delivery under regional anesthesia. If metoclopramide were found to be an analgesic adjunct in these patients, it would offer an additional impetus for its routine use. Methods. After elective cesarean delivery under spinal anesthesia, 32 patients were monitored for initial and 24-hour postoperative morphine requirements via intravenous patient- controlled analgesia. These patients were divided into two groups. Prior to spinal block, group 1 (n = 17) received 10 mg intravenous metoclopramide, and group 2 (n = 15) received an intravenous saline placebo. Results. No differences were found between groups in the time from spinal placement to the time of pain onset, the amount of morphine necessary to initially achieve comfort, or 24-hour postoperative morphine requirements. (P > .05). Conclusions. This study demonstrates that metoclopramide decreases intraoperative nausea but does not supplement analgesia in patients undergoing elective cesarean delivery.

KW - Cesarean delivery

KW - Metoclopramide

KW - Morphine

KW - Patient-controlled analgesia

UR - http://www.scopus.com/inward/record.url?scp=0030879948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030879948&partnerID=8YFLogxK

M3 - Article

C2 - 9338902

AN - SCOPUS:0030879948

VL - 22

SP - 424

EP - 427

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 5

ER -